Wild-type RAS signaling is an essential therapeutic target in RAS-mutated cancers

被引：0
|
作者：
Sealover, Nancy [1 ]
Finniff, Bridget [1 ]
Kortum, Robert [1 ]
机构：
[1] USUHS, Bethesda, MD USA
来源：
MOLECULAR CANCER RESEARCH | 2023年 / 21卷 / 05期
关键词：
D O I：
10.1158/1557-3125.RAS23-B033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B033
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Wild-type RAS signaling is an essential therapeutic target in RAS-mutated cancers
    Sealover, Nancy E.
    Finniff, Bridget
    Hughes, Jacob
    Lee, Hyun
    Kortum, Robert L.
    CANCER RESEARCH, 2024, 84 (06)
  • [2] WT RAS signaling is an essential therapeutic target in RAS mutated cancers
    Sealover, Nancy E.
    Kortum, Robert L.
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Ferroptotic small molecules for the treatment of Ras-mutated cancers
    Fedorka, Sara
    Taylor, William R.
    Tillekeratne, Viranga
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [4] Therapeutic efficacy of trametinib and ganitumab in RAS-mutated rhabdomyosarcoma
    Yohe, Marielle E.
    Hebron, Katie E.
    Wan, Xiaolin
    Roth, Jacob S.
    Liewehr, David J.
    Sealover, Nancy E.
    Stauffer, Stacey
    Feehan-Nelson, Olivia
    Sun, Wenyue
    Isanogle, Kristine A.
    Robinson, Christina M.
    James, Amy
    Awasthi, Parirokh
    Shankarappa, Priya
    Liu, Xiaoling
    Lei, Haiyan
    Butcher, Donna
    Smith, Roberta
    Edmonson, Elijah F.
    Chen, Jin-Qui
    Kedei, Noemi
    Peer, Cody S.
    Shern, Jack F.
    Figg, W. Douglas
    Chen, Lu
    Hall, Matthew D.
    Difillipantonio, Simone
    Barr, Frederic G.
    Kortum, Robert L.
    Vaseva, Angelina V.
    Khan, Javed
    CLINICAL CANCER RESEARCH, 2022, 28 (18)
  • [5] Canine hemangiosarcoma as a model for RAS-mutated human cancers: Preliminary data
    White, Michelle E.
    Harvey, Garrett
    Rodrigues, Lucas
    Schwalbach, Chase
    Girimonte, Dorothy
    Miller, Aubrey
    Hull, Abigail
    Lambert, Lindsay
    Lopes, Christina
    Post, Gerald
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [6] Wild-Type RAS: Keeping Mutant RAS in CHK
    Anastassiadis, Theonie
    Brown, Eric J.
    CANCER CELL, 2014, 25 (02) : 137 - 138
  • [7] NeoRAS: Incidence of RAS reversion from RAS mutated to RAS wild type
    Henry, Jason
    Willis, Jason
    Parseghian, Christine Megerdichian
    Raghav, Kanwal Pratap Singh
    Johnson, Benny
    Dasari, Arvind
    Stone, David
    Jeyakumar, Nikeshan
    Coker, Oluwadara
    Raymond, Victoria M.
    Lanman, Richard B.
    Overman, Michael J.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [8] The Role of Wild-Type RAS in Oncogenic RAS Transformation
    Sheffels, Erin
    Kortum, Robert L.
    GENES, 2021, 12 (05)
  • [9] Refametinib in RAS-mutated hepatocellular cancer
    Das, Manjulika
    LANCET ONCOLOGY, 2018, 19 (08): : E389 - E389
  • [10] New Therapeutic Targets in RAS Wild-type Pancreatic Cancer
    Diab, Maria
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (12) : 1556 - 1562
12345